Blood levels of vitamin D negatively correlated with stages of the disease, and patients with severe vitamin D deficiency had more than a 2-fold increased risk of dying during the study, according to Dr. Oliver Waidmann, senior author of the Alimentary Pharmacology and Therapeutics study.
Finkelmeier, F., Kronenberger, B., Köberle, V., Bojunga, J., Zeuzem, S., Trojan, J., Piiper, A. and Waidmann, O. (2014), Severe 25-hydroxyvitamin D deficiency identifies a poor prognosis in patients with hepatocellular carcinoma – a prospective cohort study. Alimentary Pharmacology & Therapeutics, 39: 1204–1212. doi: 10.1111/apt.12731
Provided by Wiley
This Phys.org Science News Wire page contains a press release issued by an organization mentioned above and is provided to you “as is” with little or no review from Phys.Org staff.